161 related articles for article (PubMed ID: 35510091)
21. Clostridioides difficile infections, recurrences, and clinical outcomes in real-world settings from 2015 to 2019: The RECUR England study.
Ghosh S; Antunes A; Rinta-Kokko H; Chaparova E; Lay-Flurrie S; Tricotel A; Andersson FL
Int J Infect Dis; 2024 Mar; 140():31-38. PubMed ID: 38185320
[TBL] [Abstract][Full Text] [Related]
22. Impact of recurrent hospitalization for
Venkat PG; Nguyen NH; Luo J; Qian AS; Khanna S; Singh S
Therap Adv Gastroenterol; 2022; 15():17562848221141501. PubMed ID: 36518884
[TBL] [Abstract][Full Text] [Related]
23. Estimating excess mortality and economic burden of Clostridioides difficile infections and recurrences during 2015-2019: The RECUR England study.
Ghosh S; Antunes A; Rinta-Kokko H; Chaparova E; Lay-Flurrie S; Tricotel A; Andersson FL
Int J Infect Dis; 2024 May; 142():106967. PubMed ID: 38368927
[TBL] [Abstract][Full Text] [Related]
24. Recurrent Clostridium difficile infection in intensive care unit patients.
Jasiak NM; Alaniz C; Rao K; Veltman K; Nagel JL
Am J Infect Control; 2016 Jan; 44(1):36-40. PubMed ID: 26432184
[TBL] [Abstract][Full Text] [Related]
25. Predictors and burden of hospital readmission with recurrent Clostridioides difficile infection: a French nation-wide inception cohort study.
Dinh A; Le Monnier A; Emery C; Alami S; Torreton É; Duburcq A; Barbier F
Eur J Clin Microbiol Infect Dis; 2019 Jul; 38(7):1297-1305. PubMed ID: 30941532
[TBL] [Abstract][Full Text] [Related]
26. Bezlotoxumab in Patients with a Primary
Granata G; Schiavone F; Pipitone G
Antibiotics (Basel); 2022 Oct; 11(11):. PubMed ID: 36358149
[TBL] [Abstract][Full Text] [Related]
27. Incidence, Attributable Mortality, and Healthcare and Out-of-Pocket Costs of Clostridioides difficile Infection in US Medicare Advantage Enrollees.
Yu H; Alfred T; Nguyen JL; Zhou J; Olsen MA
Clin Infect Dis; 2023 Feb; 76(3):e1476-e1483. PubMed ID: 35686435
[TBL] [Abstract][Full Text] [Related]
28. Budget Impact Analysis of REBYOTA™ (Fecal Microbiota, Live-jslm [FMBL]) for Preventing Recurrent Clostridioides difficile Infection in the US.
Lodise T; Guo A; Yang M; Cook EE; Song W; Yang D; Wang Q; Zhao A; Bochan M
Adv Ther; 2023 Jun; 40(6):2801-2819. PubMed ID: 37093360
[TBL] [Abstract][Full Text] [Related]
29. Mortality, Hospital Costs, Payments, and Readmissions Associated With
Drozd EM; Inocencio TJ; Braithwaite S; Jagun D; Shah H; Quon NC; Broderick KC; Kuti JL
Infect Dis Clin Pract (Baltim Md); 2015 Nov; 23(6):318-323. PubMed ID: 27885315
[TBL] [Abstract][Full Text] [Related]
30. Real-world Experience of Bezlotoxumab for Prevention of
Hengel RL; Ritter TE; Nathan RV; Van Anglen LJ; Schroeder CP; Dillon RJ; Marcella SW; Garey KW
Open Forum Infect Dis; 2020 Apr; 7(4):ofaa097. PubMed ID: 32363211
[TBL] [Abstract][Full Text] [Related]
31. Prospective Study on Incidence, Risk Factors and Outcome of Recurrent
Granata G; Petrosillo N; Adamoli L; Bartoletti M; Bartoloni A; Basile G; Bassetti M; Bonfanti P; Borromeo R; Ceccarelli G; De Luca AM; Di Bella S; Fossati S; Franceschini E; Gentile I; Giacobbe DR; Giacometti E; Ingrassia F; Lagi F; Lobreglio G; Lombardi A; Lupo LI; Luzzati R; Maraolo AE; Mikulska M; Mondelli MU; Mularoni A; Mussini C; Oliva A; Pandolfo A; Rogati C; Trapani FF; Venditti M; Viale P; Caraffa E; Cataldo MA; On Behalf Of The ReCloDi Recurrence Of Clostridioides Difficile Infection Study Group
J Clin Med; 2021 Mar; 10(5):. PubMed ID: 33800334
[TBL] [Abstract][Full Text] [Related]
32. Burden of Clostridioides difficile infection (CDI) - a systematic review of the epidemiology of primary and recurrent CDI.
Finn E; Andersson FL; Madin-Warburton M
BMC Infect Dis; 2021 May; 21(1):456. PubMed ID: 34016040
[TBL] [Abstract][Full Text] [Related]
33. Risk factors for recurrent Clostridium difficile infection in hematopoietic stem cell transplant recipients.
Huang AM; Marini BL; Frame D; Aronoff DM; Nagel JL
Transpl Infect Dis; 2014 Oct; 16(5):744-50. PubMed ID: 25040545
[TBL] [Abstract][Full Text] [Related]
34. Burden of Clostridium difficile-associated disease among patients residing in nursing homes: a population-based cohort study.
Yu H; Baser O; Wang L
BMC Geriatr; 2016 Nov; 16(1):193. PubMed ID: 27884118
[TBL] [Abstract][Full Text] [Related]
35. Incidence of and risk factors for recurrent Clostridioidesdifficile infection in Japan using a claims database: A retrospective cohort study.
Mikamo H; Kondo T; Okuyama K; Marcella SW; Ruzicka DJ
Anaerobe; 2020 Feb; 61():102139. PubMed ID: 31830597
[TBL] [Abstract][Full Text] [Related]
36. Prognostic factors for severe and recurrent Clostridioides difficile infection: a systematic review.
van Rossen TM; Ooijevaar RE; Vandenbroucke-Grauls CMJE; Dekkers OM; Kuijper EJ; Keller JJ; van Prehn J
Clin Microbiol Infect; 2022 Mar; 28(3):321-331. PubMed ID: 34655745
[TBL] [Abstract][Full Text] [Related]
37. Clostridioides difficile infection (CDI): A pan-European multi-center cost and resource utilization study, results from the Combatting Bacterial Resistance in Europe CDI (COMBACTE-CDI).
Wingen-Heimann SM; Davies K; Viprey VF; Davis G; Wilcox MH; Vehreschild MJGT; Lurienne L; Bandinelli PA; Cornely OA; Vilken T; Hopff SM; Vehreschild JJ;
Clin Microbiol Infect; 2023 May; 29(5):651.e1-651.e8. PubMed ID: 36586512
[TBL] [Abstract][Full Text] [Related]
38. Adoption and Trends in Uptake of Updated ICD-10 Codes for
Deshpande A; Chen Y; Boye-Codjoe E; Obi EN
Open Forum Infect Dis; 2022 Dec; 9(12):ofac622. PubMed ID: 36519119
[TBL] [Abstract][Full Text] [Related]
39. Fidaxomicin versus metronidazole, vancomycin and their combination for initial episode, first recurrence and severe Clostridioides difficile infection - An observational cohort study.
Polivkova S; Krutova M; Capek V; Sykorova B; Benes J
Int J Infect Dis; 2021 Feb; 103():226-233. PubMed ID: 33188906
[TBL] [Abstract][Full Text] [Related]
40. Clostridioides difficile infection in immunocompromised hospitalized patients is associated with a high recurrence rate.
Avni T; Babitch T; Ben-Zvi H; Hijazi R; Ayada G; Atamna A; Bishara J
Int J Infect Dis; 2020 Jan; 90():237-242. PubMed ID: 31672656
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
